
Magnetic Nanoparticle Enabled Highly Sensitive and Accurate Assays

High Yield Sample Preparation

- Precision
- Rare Targets
- Automation Ready
- Screening
- Monitoring & Treatment Guidance
Comprehensive and Customizable
Cancer Gene Panel
AKT1 | ALK* | AR | BRAF* | BRCA1* | BRCA2* | CD274* | EGFR* |
ERBB2* | ESR1* | FGFR1* | FGFR2* | FGFR3* | KRAS* | MET* | MLH1 |
MSH2 | MSH6 | NRAS | NTRK1* | NTRK2* | NTRK3* | PALB2 | PDGFRA* |
PIK3CA* | PMS2 | PTEN | RB1 | RET* | ROS1* | STK11 | TP53* |
ATM | BARD1 | BRIP1 | CDH1 | CHEK2 | CTNNB1 | EPCAM | EZH2 |
ERBB3 | FOXA1 | GATA3 | IDH1 | MAP3K1 | MYC | MUTYH | NF1 |
RAD51C | RAD51D | KIT* | CDK12 | NOTCH1 | RPTOR | CCND1 | MDM2 |
IGF1R | CDK4 | CDK6 | PPP2R2A* | TSC1 | JAK2* | SMO | Other |
* Genes with FDA approved therapeutic products
Robust Workflow

- Blood, Tissue, Saliva, Pleural Fluid and More
- Compatible with Multiple Sequencers
- High NGS Data Efficiency
- Consistent Results
High Sensitivity and Specificity
NVIGEN X-
Standard Depth
VAF | Sensitivity | Specificity |
0.1-0.25% | > 60-80% | 95-99% |
0.25-0.5% | > 90-95% | 99% |
> 0.5% | 99% | 99% |
Learn More
NVIGEN X-
High Depth
VAF | Sensitivity | Specificity |
0.1-0.25% | > 90-95% | 95-99% |
0.25-0.5% | > 97-99% | 99% |
> 0.5% | 99% | 99% |
Learn More
Cleaner and More Accurate NGS Data

Left: NVIGEN X assay for 17 patients and 14 normal human samples shows the assay enables clear differentiation between patients and normal humans. Right: Two sample t-test from SciPy library shows statistical significance (p=1.73E-05) to differentiate between breast cancer patients and normal humans based on gene alterations detected with NVIGEN X assay.
Integrated Protein Biomarker Analyses

- Magnetic Nanoparticle Enabled
- Streamlined Workflow
- Variable Multiplex Formats
- Customizable Protein Markers: PD-L1, Her2, EGFR, Trop-2, CEA, CA15-3, TNF-alpha, IL-6…
CTC Capture and Analyses in Parallel
With ctDNA
- Magnetic CTC Capture for DNA/RNA/Protein Analyses
- Clinically Significant Complementary and Confirmative Information
- Screening, Surveillance and Treatment Guidance

Automation Ready

- Streamlined Sample Process
- High Consistency
- Program Support
- Personalized Cancer Care
- Aging and Neurodegenerative Diseases
- High Sensitivity for Rare Target Identification and Drug Development
- Complex Biomarker Discovery
- Single Cell or Intracellular Molecules

Cancer Patient Case Study

- Benchmark Validation
- Serial Sampling and Monitoring
- Treatment Guidance
- Life Saving
Save Lives with NVIGEN
Enhanced Disease Understanding
Preventative & Curative Health Care

Related Products
- MagVigen™ – cfDNA Capture Kit (Cat#K61003)
- MagVigen™ – EASY DNA Size Select Kit (Cat#K61001-EASY)
- MagVigen™ – Extended DNA Size Select Kit (Cat#K61001-Extend)
- MagVigen™ – Streptavidin DNA Capture (Cat#K61002)
- MagVigen™ – anti EpCAM, Human Kit
(Cat# K51001) - MagVigen™ – anti CD45, Human Kit
(Cat# K51002)
- MagVigen™ – Streptavidin Protein Capture (Cat#21005P)
- MagVigen™ – Steptavidin Cell Capture (Cat#21005C)
- MagVigen™ PD-L1 On-Beads ELISA Kit (Cat#KE7101)
- MagVigen™ Her2 On-Beads ELISA Kit (Cat#KE7102)
- MagVigen™ EGFR On-Beads ELISA Kit (Cat#KE710)
- MagVigen™ – anti CD19, Human Kit
(Cat# K51005)